Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Collegium Pharmaceutical Inc’s stock clocked out at $46.21, up 1.16% from its previous closing price of $45.68. In other words, the price has increased by $1.16 from its previous closing price. On the day, 0.55 million shares were traded. COLL stock price reached its highest trading level at $47.55 during the session, while it also had its lowest trading level at $45.66.
Ratios:
To gain a deeper understanding of COLL’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.05. For the most recent quarter (mrq), Quick Ratio is recorded 1.27 and its Current Ratio is at 1.36. In the meantime, Its Debt-to-Equity ratio is 3.41 whereas as Long-Term Debt/Eq ratio is at 3.17.
Upgrades & Downgrades
In the most recent recommendation for this company, Barclays on December 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $58.
On January 10, 2025, Needham Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $46.
H.C. Wainwright Upgraded its Neutral to Buy on July 30, 2024, while the target price for the stock was maintained at $47.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 05 ’25 when RITA BALICE-GORDON bought 3,650 shares for $47.03 per share.
Dreyer Scott sold 17,600 shares of COLL for $847,855 on Dec 08 ’25. The EVP & Chief Commercial Officer now owns 103,613 shares after completing the transaction at $48.17 per share. On Dec 05 ’25, another insider, Balice-Gordon Rita J., who serves as the Director of the company, sold 3,650 shares for $47.03 each. As a result, the insider received 171,673 and left with 52,629 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COLL now has a Market Capitalization of 1460743168 and an Enterprise Value of 2111148160. As of this moment, Collegium’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.76, and their Forward P/E ratio for the next fiscal year is 5.77. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.93 while its Price-to-Book (P/B) ratio in mrq is 5.31. Its current Enterprise Value per Revenue stands at 2.789 whereas that against EBITDA is 5.262.
Stock Price History:
The Beta on a monthly basis for COLL is 0.64, which has changed by 0.370126 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, COLL has reached a high of $50.79, while it has fallen to a 52-week low of $23.23. The 50-Day Moving Average of the stock is 3.16%, while the 200-Day Moving Average is calculated to be 31.69%.
Shares Statistics:
It appears that COLL traded 487.52K shares on average per day over the past three months and 450450 shares per day over the past ten days. A total of 31.60M shares are outstanding, with a floating share count of 30.56M. Insiders hold about 3.32% of the company’s shares, while institutions hold 118.91% stake in the company. Shares short for COLL as of 1765756800 were 5353853 with a Short Ratio of 10.98, compared to 1763078400 on 5679812. Therefore, it implies a Short% of Shares Outstanding of 5353853 and a Short% of Float of 20.28.
